BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15064498)

  • 1. Diagnostic and prognostic significance of the methylation status of Myf-3 in lymphoproliferative disorders.
    Taylor JM; Kay PH; Spagnolo DV
    Methods Mol Med; 2004; 97():251-65. PubMed ID: 15064498
    [No Abstract]   [Full Text] [Related]  

  • 2. Myf-3 hypermethylation in malignant lymphoproliferative disorders.
    Kay PH; Taylor J; Kees UR; Baker DL; Spagnolo DV
    Int J Cancer; 1995 Sep; 62(6):797-9. PubMed ID: 7558433
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypermethylation of the myogenic gene Myf-3 in human breast carcinomas.
    Hähnel R; Harvey J; Kay P
    Anticancer Res; 1996; 16(4A):2111-5. PubMed ID: 8712752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnositc significance of Myf-3 hypermethylation in malignant lymphoproliferative disorders.
    Taylor JM; Kay PH; Spagnolo DV
    Leukemia; 2001 Apr; 15(4):583-9. PubMed ID: 11368360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that DNA methylation imbalance is not involved in the development of malignant mesothelioma.
    Bagwe AN; Kay PH; Spagnolo DV
    Anticancer Res; 1997; 17(5A):3341-3. PubMed ID: 9413169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNMT1 gene copy number does not influence susceptibility to development of malignant lymphoproliferative disease.
    Franchina M; Kay PH
    Anticancer Res; 2002; 22(6A):3405-7. PubMed ID: 12530095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and molecular genetic studies in the diagnosis of immune-related lymphoproliferative disorders.
    Said J
    Hum Pathol; 2003 Apr; 34(4):341-5. PubMed ID: 12733113
    [No Abstract]   [Full Text] [Related]  

  • 8. Clonality analysis for antigen receptor genes: preliminary results from the Biomed-2 concerted action PL 96-3936.
    van Krieken JH; Langerak AW; San Miguel JF; Parreira A; Smith JL; Morgan GM; Kneba M; Macintyre EA; van Dongen JJ
    Hum Pathol; 2003 Apr; 34(4):359-61. PubMed ID: 12733116
    [No Abstract]   [Full Text] [Related]  

  • 9. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein.
    Park IY; Sohn BH; Yu E; Suh DJ; Chung YH; Lee JH; Surzycki SJ; Lee YI
    Gastroenterology; 2007 Apr; 132(4):1476-94. PubMed ID: 17408664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of p300 gene promoter methylation in acute leukemia.
    Chim CS; Wong AS; Kwong YL
    Cancer Genet Cytogenet; 2004 Apr; 150(2):164-7. PubMed ID: 15066326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Malignant disorders of the lymphatic system].
    Bast EJ; de Gast GC; Schuurman HJ
    Ned Tijdschr Geneeskd; 1986 Sep; 130(38):1695-9. PubMed ID: 3762773
    [No Abstract]   [Full Text] [Related]  

  • 12. New SNPs in the coding and 5' flanking regions of porcine MYOD1 (MYF3) and MYF5 genes.
    Urbański P; Kurył J
    J Appl Genet; 2004; 45(3):325-9. PubMed ID: 15306724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic DNA methylation marker in serum of cancer patients.
    Müller HM; Fiegl H; Widschwendter A; Widschwendter M
    Ann N Y Acad Sci; 2004 Jun; 1022():44-9. PubMed ID: 15251938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma-based detection of clonality in lymphoid malignancies.
    Yeh CH; Tseng R; Albitar M
    Eur J Haematol; 2009 Jun; 82(6):450-3. PubMed ID: 19187275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of clonal rearrangement of T-cell receptor genes in the diagnosis of primary cutaneous CD30 lymphoproliferative disorders.
    Greisser J; Palmedo G; Sander C; Kutzner H; Kazakov DV; Roos M; Burg G; Kempf W
    J Cutan Pathol; 2006 Nov; 33(11):711-5. PubMed ID: 17083688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers.
    Koga Y; Kitajima Y; Miyoshi A; Sato K; Kitahara K; Soejima H; Miyazaki K
    Ann Surg Oncol; 2005 May; 12(5):354-63. PubMed ID: 15915369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA gene expression in malignant lymphoproliferative disorders.
    Xu W; Li JY
    Chin Med J (Engl); 2007 Jun; 120(11):996-9. PubMed ID: 17624268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer.
    Leung WK; To KF; Chu ES; Chan MW; Bai AH; Ng EK; Chan FK; Sung JJ
    Br J Cancer; 2005 Jun; 92(12):2190-4. PubMed ID: 15942635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identical phenotype in patients with somatic and germline CD95 mutations requires a new diagnostic approach to autoimmune lymphoproliferative syndrome.
    Rössler J; Enders A; Lahr G; Heitger A; Winkler K; Fuchs H; Kopp M; Niemeyer C; Ehl S
    J Pediatr; 2005 Nov; 147(5):691-4. PubMed ID: 16291365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of p16INK4A hypermethylation with hepatitis B virus X protein expression in the early stage of HBV-associated hepatocarcinogenesis.
    Zhu R; Li BZ; Li H; Ling YQ; Hu XQ; Zhai WR; Zhu HG
    Pathol Int; 2007 Jun; 57(6):328-36. PubMed ID: 17539963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.